These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Parenteral iron therapy: problems and possible solutions]. Hoigné R; Breymann C; Künzi UP; Brunner F Schweiz Med Wochenschr; 1998 Apr; 128(14):528-35. PubMed ID: 9592894 [TBL] [Abstract][Full Text] [Related]
7. Single total-dose intravenous infusion of iron-dextran. Lee DT; Robinson SC Can Med Assoc J; 1967 Aug; 97(8):377-9. PubMed ID: 6037391 [No Abstract] [Full Text] [Related]
8. Iron dextran--its use in surgery by total dose infusion (T.D.I.) as an alternative to blood transfusion. Humphries SV Cent Afr J Med; 1971 Dec; 17(12):255-6. PubMed ID: 5145127 [No Abstract] [Full Text] [Related]
9. Iron-dextran anaphylaxis: occurrence after a negative test dose. Lewinter P J Med Soc N J; 1970 Mar; 67(3):116-7. PubMed ID: 5264625 [No Abstract] [Full Text] [Related]
11. Safety and efficacy of total dose infusion of iron dextran in iron deficiency anaemia. Reddy CM; Kathula SK; Ali SA; Bekal R; Walsh M Int J Clin Pract; 2008 Mar; 62(3):413-5. PubMed ID: 18005041 [TBL] [Abstract][Full Text] [Related]
12. Iron dextran-induced anaphylaxis in a goat (Capra hircus). Ladiges WC; Garlinghouse LE Lab Anim Sci; 1981 Aug; 31(4):421-2. PubMed ID: 7311471 [No Abstract] [Full Text] [Related]
13. [Complications in intravenous iron-dextran treatment. Criteria for their prevention]. Ambriz R; Loera SJ; Avilés A; Sinco A; Pizzuto J Gac Med Mex; 1983 Aug; 119(8):326-9. PubMed ID: 6680107 [No Abstract] [Full Text] [Related]
14. Is there a difference between the allergic potencies of the iron sucrose and low molecular weight iron dextran? Sav T; Tokgoz B; Sipahioglu MH; Deveci M; Sari I; Oymak O; Utas C Ren Fail; 2007; 29(4):423-6. PubMed ID: 17497463 [TBL] [Abstract][Full Text] [Related]
15. The effect of varying concentrations of intravenous iron dextran (Imferon) on the complication rate. Roe PF East Afr Med J; 1968 Nov; 45(11):713-9. PubMed ID: 5721118 [No Abstract] [Full Text] [Related]
16. Falsely decreased total serum calcium concentration associated with iron dextran injection. Newsom L; Erstad BL; Nakazato PZ; Daller JA Pharmacotherapy; 1995; 15(6):789-92. PubMed ID: 8602390 [TBL] [Abstract][Full Text] [Related]
17. Comparison of intravenous iron sucrose versus low-molecular-weight iron dextran in chronic kidney disease. Sinha S; Chiu DY; Peebles G; Kolakkat S; Lamerton E; Fenwick S; Kalra PA J Ren Care; 2009 Jun; 35(2):67-73. PubMed ID: 19432851 [TBL] [Abstract][Full Text] [Related]
18. High-molecular weight iron dextran: a wolf in sheep's clothing? Rodgers GM; Auerbach M; Cella D; Chertow GM; Coyne DW; Glaspy JA; Henry DH J Am Soc Nephrol; 2008 May; 19(5):833-4. PubMed ID: 18369084 [No Abstract] [Full Text] [Related]
19. Toxicity of parenteral iron dextran therapy. Burns DL; Pomposelli JJ Kidney Int Suppl; 1999 Mar; 69():S119-24. PubMed ID: 10084295 [TBL] [Abstract][Full Text] [Related]
20. [Iron deficiency anemia in the elderly]. Wigler I; Weintraub M; Soferman G; Landau E; Liron M Harefuah; 1983 Jul; 105(1-2):1-3. PubMed ID: 6629177 [No Abstract] [Full Text] [Related] [Next] [New Search]